-
Mashup Score: 1Complete Functional Recovery After Radical Nephrectomy Linked to Better Survival - Renal and Urology News - 6 day(s) ago
Investigators studied the prevalence, predictors, and outcomes of complete functional recovery after radical nephrectomy.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
Increases seen in some countries, mostly in Africa, Asia, Latin America and the Caribbean, and Central and Eastern Europe
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
In most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent 5-year period, but increasing trends were seen in some countries. https://t.co/puTTBZRr7E
-
-
Mashup Score: 0Women Report Less Poststroke Medication Adherence Than Men - 7 day(s) ago
Women more likely to report nonadherence to cholesterol-lowering drugs and antiplatelets
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Women more likely to report nonadherence to cholesterol-lowering drugs and antiplatelets. https://t.co/xWzXiu5Uzw
-
-
Mashup Score: 0Salvage Radical Prostatectomy Carries Higher Risks of Postop Complications - Renal and Urology News - 7 day(s) ago
Investigators quantified the risk of complications, such as urinary leak and rectal injury, after salvage vs primary surgery for prostate cancer.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Compared with primary radical prostatectomy (RP) for prostate cancer, salvage RP after radiation therapy is associated with increased risks of 30-day postoperative complications, according to research presented at #SUO24. #pcsm https://t.co/GHGO2ecYxQ
-
-
Mashup Score: 0
Azmiro (testosterone cypionate) is now available in a prefilled syringe formulation for testosterone replacement therapy.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Azmiro (testosterone cypionate) is now available in a prefilled syringe formulation for testosterone replacement therapy in men with a deficiency or absence of endogenous testosterone. https://t.co/CzZ9fWiSfF
-
-
Mashup Score: 0GSK Withdraws Jesduvroq From the US Market - 7 day(s) ago
GSK has made the decision to withdraw Jesduvroq (daprodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, from the US market.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
GSK has made the decision to withdraw Jesduvroq (daprodustat) from the US market. https://t.co/Bk9vfmSwM0
-
-
Mashup Score: 0Partial vs Radical Cystectomy Is a Viable Option for Muscle-Invasive Bladder Cancer - Renal and Urology News - 7 day(s) ago
Investigators studied cancer control after partial vs radical cystectomy for muscle-invasive bladder cancer.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Partial and radical cystectomy offer comparable oncologic outcomes in well-selected patients with muscle-invasive bladder cancer, investigators reported at #SUO24#blcsm. https://t.co/3Ku1PVraKN
-
-
Mashup Score: 0
Hazard ratio for dementia higher in those with stroke compared with reference population, those with acute myocardial infarction
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Almost 1 in 5 stroke survivors are diagnosed with dementia, with increased risk lasting for 20 years after stroke. https://t.co/qsCw8Hqqgy
-
-
Mashup Score: 0Diabetic Retinopathy Screening With AI Underutilized - 8 day(s) ago
Diabetic retinopathy screening with AI was associated with higher referral rates to optical coherence tomography but remains underutilized.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Artificial intelligence (AI)-based diabetic retinopathy imaging vs traditional screening methods is associated with more referrals for optical coherence tomography (OCT) but remains underutilized. https://t.co/nrh3GkvE0O
-
-
Mashup Score: 0Inconsistent ICI Use After Disease Progression May Impact Trial Outcomes - Renal and Urology News - 8 day(s) ago
Researchers discovered inconsistent use of immune checkpoint inhibitors (ICIs) after disease progression in patients who were enrolled in the control arms of phase 3 trials testing ICI therapy.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Patients with metastatic renal cell carcinoma (RCC) who are assigned to the control arms of phase 3 immune checkpoint inhibitor (ICI) trials are not consistently given ICIs after their disease progresses. https://t.co/BR465xLfI8
-
Investigators identified the prevalence, predictors, and survival outcomes of complete functional recovery after radical nephrectomy for #kidney cancer. https://t.co/aNAxiPYpYi #kcsm #SUO24